Tychon Bioscience
About:
Tychon Bioscience is a biotechnology company commercializing adaptive immunotherapy technology.
Website: https://tychonbio.com
Description:
Tychon Bioscience is a biotechnology company commercializing adaptive immunotherapy technology. Its PARs harnesses the power of protein dimerization to produce chemically self-assembling nanorings that form a construct to combine a patient’s T-lymphocytes and a host of cancer-seeking antigens creating various cell therapies with selective anti-tumor capabilities.
Total Funding Amount:
$1.62M
Headquarters Location:
Minneapolis, Minnesota, United States
Founded Date:
2015-01-01
Contact Email:
info(AT)tychonbio.com
Founders:
Danny J. Cunagin, Troy Kopischke
Number of Employees:
11-50
Last Funding Date:
2019-12-31
IPO Status:
Private
Industries:
© 2025 bioDAO.ai